A channel-by-channel playbook for research peptide brands: which paid platforms tolerate the category, how to structure compliant offers and subscriptions, and how email and affiliates carry the margin. Includes the payment processors that approve peptide merchants.
Marketing research peptides is a constrained optimization problem, not a creative one. The constraint is that no channel will let you sell the product the way the customer actually thinks about it, so the entire funnel has to be built around what you can defensibly say. The winning register is research-use-only: describe the compound, the purity documentation, the handling requirements and the vendor's operational credibility, and let the buyer supply the intent. Channel mix follows from that constraint — Meta carries scale when creative is engineered for review, Google protects branded search and captures bottom-of-funnel demand, email and SMS carry the second and third order, and organic content builds the credibility layer that paid traffic converts against. The brands that scale are the ones that treat compliance, creative, funnel and lifecycle as one system.
By marketing research-use-only material to a research audience and never implying human therapeutic use. That means describing the compound, purity documentation, storage and handling rather than results, and keeping that framing identical across the ad, the landing page and the checkout.
Meta carries the most scale when the creative is engineered for policy review, while Google is better at capturing demand that already exists and defending branded search. Most brands should prove profitability on one channel before layering on TikTok or X.
You can work with creators, but the creator's script is your liability. Any outcome claim a creator makes is treated as your claim by the platform, so creator content has to be reviewed against the same standard as your own copy.
Enough to produce a statistically meaningful number of conversions rather than a fixed dollar figure. Testing budgets that generate only a handful of purchases produce noise, and decisions made on that noise are the most common cause of prematurely killed campaigns.
Scaling acquisition before retention, processing and fulfillment can absorb it. New spend then exposes every weakness at once: stockouts, failed payments and support backlogs all hit in the same week.